文献速递心血管CTDSA

冠周脂肪衰减指数对冠状动脉支架内再狭窄的预测价值

Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis.
PubMed 文献 · Eur Radiol · 2024-01-15

本研究纳入2017年1月至2019年12月在本院接受经皮冠状动脉介入治疗(PCI)前1周内行冠状动脉CT血管成像(CCTA)且有随访有创冠状动脉造影(ICA)或CCTA的患者,测量支架置入部位的冠周脂肪衰减指数(FAI),随访期间40枚(22.2%,40/180)支架发生支架内再狭窄(ISR)。冠周FAI与ISR风险升高独立相关(校正OR=1.12,p=0.028),最佳截断值为-69.6 HU,将二分类冠周FAI纳入现有ISR预测模型可显著提高预测能力(AUC变化=+0.064;p=0.001)。

要点

  • 支架置入部位冠周FAI与支架内再狭窄独立相关(校正OR=1.12,p=0.028)。
  • 冠周FAI预测支架内再狭窄的最佳截断值为-69.6 HU。
  • 将二分类冠周FAI纳入现有预测模型可显著提高ISR预测能力(AUC变化=+0.064;p=0.001)。

核心结论

  • 支架置入部位冠周FAI与支架内再狭窄独立相关,并可提高现有ISR预测模型的预测能力。

研究设计与样本

  • 研究纳入2017年1月至2019年12月在本院PCI前1周内行CCTA且有随访ICA或CCTA的患者,共126例患者180个目标病变,采用混合效应logistic回归模型在病变水平分析冠周FAI与ISR的关联。

诊断标准与关键数值

  • ISR定义为随访ICA或CCTA显示支架内区域直径狭窄≥50%;冠周FAI预测ISR的最佳截断值为-69.6 HU;冠周FAI与ISR风险的校正OR=1.12(p=0.028);将二分类冠周FAI纳入现有ISR预测模型后AUC变化=+0.064(p=0.001)。

临床应用与阅片要点

  • 冠周FAI可用于识别支架内再狭窄高风险病变,这些病变可能从额外抗炎治疗中获益以避免支架内再狭窄。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: As a novel imaging marker, pericoronary fat attenuation index (FAI) reflects the local coronary inflammation which is one of the major mechanisms for in-stent restenosis (ISR). We aimed to validate the ability of pericoronary FAI to predict ISR in patients undergoing percutaneous coronary intervention (PCI).

MATERIALS AND METHODS: Patients who underwent coronary CT angiography (CCTA) before PCI within 1 week between January 2017 and December 2019 at our hospital and had follow-up invasive coronary angiography (ICA) or CCTA were enrolled. Pericoronary FAI was measured at the site where stents would be placed. ISR was defined as ≥ 50% diameter stenosis at follow-up ICA or CCTA in the in-stent area. Multivariable analysis using mixed effects logistic regression models was performed to test the association between pericoronary FAI and ISR at lesion level.

RESULTS: A total of 126 patients with 180 target lesions were included in the study. During 22.5 months of mean interval time from index PCI to follow-up ICA or CCTA, ISR occurred in 40 (22.2%, 40/180) stents. Pericoronary FAI was associated with a higher risk of ISR (adjusted OR = 1.12, p = 0.028). The optimum cutoff was - 69.6 HU. Integrating the dichotomous pericoronary FAI into current state of the art prediction model for ISR improved the prediction ability of the model significantly (△area under the curve = + 0.064; p = 0.001).

CONCLUSION: Pericoronary FAI around lesions with subsequent stent placement is independently associated with ISR and could improve the ability of current prediction model for ISR.

CLINICAL RELEVANCE STATEMENT: Pericoronary fat attenuation index can be used to identify the lesions with high risk for in-stent restenosis. These lesions may benefit from extra anti-inflammation treatment to avoid in-stent restenosis.

KEY POINTS: • Pericoronary fat attenuation index reflects the local coronary inflammation. • Pericoronary fat attenuation index around lesions with subsequent stents placement can predict in-stent restenosis. • Pericoronary fat attenuation index can be used as a marker for future in-stent restenosis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lu ZF, Yin WH, Schoepf UJ, et al. Prediction value of pericoronary fat attenuation index for coronary in-stent restenosis. Eur Radiol. 2024. PMID: 38224375. doi:10.1007/s00330-023-10527-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。